These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33864752)

  • 1. Nitric oxide and dopamine metabolism converge via mitochondrial dysfunction in the mechanisms of neurodegeneration in Parkinson's disease.
    Nunes C; Laranjinha J
    Arch Biochem Biophys; 2021 Jun; 704():108877. PubMed ID: 33864752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic inhibition of respiration in brain mitochondria by nitric oxide and dihydroxyphenylacetic acid (DOPAC). Implications for Parkinson's disease.
    Nunes C; Almeida L; Laranjinha J
    Neurochem Int; 2005 Aug; 47(3):173-82. PubMed ID: 15893407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide and DOPAC-induced cell death: from GSH depletion to mitochondrial energy crisis.
    Nunes C; Barbosa RM; Almeida L; Laranjinha J
    Mol Cell Neurosci; 2011 Sep; 48(1):94-103. PubMed ID: 21708261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production.
    Tapias V; Hu X; Luk KC; Sanders LH; Lee VM; Greenamyre JT
    Cell Mol Life Sci; 2017 Aug; 74(15):2851-2874. PubMed ID: 28534083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Peculiar Facets of Nitric Oxide as a Cellular Messenger: From Disease-Associated Signaling to the Regulation of Brain Bioenergetics and Neurovascular Coupling.
    Laranjinha J; Nunes C; Ledo A; Lourenço C; Rocha B; Barbosa RM
    Neurochem Res; 2021 Jan; 46(1):64-76. PubMed ID: 32193753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
    Bisaglia M; Filograna R; Beltramini M; Bubacco L
    Ageing Res Rev; 2014 Jan; 13():107-14. PubMed ID: 24389159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson's disease.
    Haddad D; Nakamura K
    FEBS Lett; 2015 Dec; 589(24 Pt A):3702-13. PubMed ID: 26526613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-S-cysteinyl-dopamine, a neurotoxic endogenous metabolite of dopamine: Implications for Parkinson's disease.
    Badillo-Ramírez I; Saniger JM; Rivas-Arancibia S
    Neurochem Int; 2019 Oct; 129():104514. PubMed ID: 31369776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
    Herrera A; Muñoz P; Steinbusch HWM; Segura-Aguilar J
    ACS Chem Neurosci; 2017 Apr; 8(4):702-711. PubMed ID: 28233992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol contributes to dopamine-neuronal loss in MPTP mouse model of Parkinson's disease: Involvement of mitochondrial dysfunctions and oxidative stress.
    Paul R; Choudhury A; Kumar S; Giri A; Sandhir R; Borah A
    PLoS One; 2017; 12(2):e0171285. PubMed ID: 28170429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review).
    Guo JD; Zhao X; Li Y; Li GR; Liu XL
    Int J Mol Med; 2018 Apr; 41(4):1817-1825. PubMed ID: 29393357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson's disease.
    Ebadi M; Sharma SK
    Antioxid Redox Signal; 2003 Jun; 5(3):319-35. PubMed ID: 12880486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease.
    Chinta SJ; Andersen JK
    Free Radic Biol Med; 2006 Nov; 41(9):1442-8. PubMed ID: 17023271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria.
    Kristal BS; Conway AD; Brown AM; Jain JC; Ulluci PA; Li SW; Burke WJ
    Free Radic Biol Med; 2001 Apr; 30(8):924-31. PubMed ID: 11295535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspective of mitochondrial biology in Parkinson's disease.
    Ammal Kaidery N; Thomas B
    Neurochem Int; 2018 Jul; 117():91-113. PubMed ID: 29550604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systems Model of Parkinson's Disease Using Biochemical Systems Theory.
    Sasidharakurup H; Melethadathil N; Nair B; Diwakar S
    OMICS; 2017 Aug; 21(8):454-464. PubMed ID: 28816645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease.
    Burbulla LF; Song P; Mazzulli JR; Zampese E; Wong YC; Jeon S; Santos DP; Blanz J; Obermaier CD; Strojny C; Savas JN; Kiskinis E; Zhuang X; Krüger R; Surmeier DJ; Krainc D
    Science; 2017 Sep; 357(6357):1255-1261. PubMed ID: 28882997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
    Sharma N; Nehru B
    Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC.
    Palazzi L; Fongaro B; Leri M; Acquasaliente L; Stefani M; Bucciantini M; Polverino de Laureto P
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.